By coupling transmembrane proteins to the actin skeleton, ezrin regulation in breast cancer cells takes part in the interaction between adhesion molecules (CD44, ICAM, E-cadherin) and tyrosine kinase growth factor, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), and their receptors (63). This evidence concerns the gene EGF and breast cancer.